Dr. Jerome I. Rotter, Executive Data Science Officer at The Lundquist Institute, has been recognized by Research.com as one of the world’s leading geneticists, earning designation as a 2026…

The Lundquist Institute for Biomedical Innovation is pleased to announce that Denise Al Alam, PhD has been awarded a prestigious S10 Instrumentation Grant from the National Institutes of Health (NIH) Office…

Researchers have uncovered important genetic factors that may contribute to aortic valve calcification, a condition in which calcium builds up on the heart’s aortic valve and…

Michelle Matter, PhD, investigator at The Lundquist Institute for Biomedical Innovation, and her lab have identified disruptions in cell stress-response and protein quality-control pathways in peripartum cardiomyopathy (PPCM),…

Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that protects the heart during pregnancy, shedding new light on the causes of…

Michelle L. Matter, PhD joins The Lundquist Institute as an expert in two areas of cardiovascular medicine: cardiomyopathies and sepsis. Underlying these two diseases is a common mechanism that involves cell adhesion…

Santosh Kesari, MD, PhD joins The Lundquist Institute as an esteemed investigator in Cancer Biology and Immunotherapeutics, bringing exceptional expertise as a board-certified neurologist, oncologist, and clinical trialist.   His multidisciplinary research…